Oral transmucosal fentanyl citrate and xerostomia [2]

Journal of Pain and Symptom Management

Volumn 30, Issue 6, 2005, Pages 496-497

  Davies, Andrew N ^a   Vriens, Joanna ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETHANECHOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; FENTANYL CITRATE; OXYCODONE; PILOCARPINE;

ABSENCE OF SIDE EFFECTS; COLON CARCINOMA; DRUG MARKETING; HUMAN; LETTER; LOZENGE; METASTASIS; MOUTH DISCOMFORT; ONSET AGE; PAIN; PRESCRIPTION; REFLUX ESOPHAGITIS; SALIVA; URINE RETENTION; XEROSTOMIA;

ADMINISTRATION, BUCCAL; ANALGESICS, OPIOID; BACK PAIN; BETHANECHOL; COLONIC NEOPLASMS; DRUG COMBINATIONS; FENTANYL; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; SPINAL NEOPLASMS; TREATMENT FAILURE; TREATMENT OUTCOME; XEROSTOMIA;

EID: 29244485895     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2005.11.006     Document Type: Letter

References (7)

1. G. Hanks Oral transmucosal fentanyl citrate for the management of breakthrough pain Eur J Palliat Care 8 2001 6 9
2. A. Davies Salivary gland dysfunction A. Davies I. Finlay Oral care in advanced disease 2005 Oxford University Press Oxford 97 113
3. I.J. Robbins Dry mouth and delayed dissolution of sublingual nitroglycerin N Engl J Med 309 1983 985
4. H.C. Everett The use of bethanechol hydrochloride with tricyclic antidepressants Am J Psychiatry 1975 1202 1204
5. J.B. Epstein, J.L. Burchell, S. Emerton, N.D. Le, and S. Silverman A clinical trial of bethanechol hydrochloride in patients with xerostomia after radiation therapy. A pilot study Oral Surg Oral Med Oral Pathol 77 1994 610 614
6. R. Twycross, A. Wilcock, S. Charlesworth, and A. Dickman Palliative care formulary 2nd ed. 2002 Radcliffe Medical Press Abingdon
7. H. Olsson, and T. Axell Objective and subjective efficacy of saliva substitutes containing mucin and carboxymethylcellulose Scand J Dent Res 99 1991 316 319